RU95112998ARU95112998/04ARU95112998ARU95112998ARU 95112998 ARU95112998 ARU 95112998ARU 95112998/04 ARU95112998/04 ARU 95112998/04ARU 95112998 ARU95112998 ARU 95112998ARU 95112998 ARU95112998 ARU 95112998A
Рязанский государственный медицинский университет им.акад.И.П.Павлова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рязанский государственный медицинский университет им.акад.И.П.ПавловаfiledCriticalРязанский государственный медицинский университет им.акад.И.П.Павлова
Priority to RU95112998ApriorityCriticalpatent/RU2083569C1/en
Publication of RU95112998ApublicationCriticalpatent/RU95112998A/en
Application grantedgrantedCritical
Publication of RU2083569C1publicationCriticalpatent/RU2083569C1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: organic chemistry. SUBSTANCE: 4-fluorobenzaldehyde thiosalicyloylhydrazone is synthesized by interaction of thiosalicyloylhydrazone with 4-fluorobenzaldehyde that has been tested with respect to excretory kidney function of white rats. Synthesized compound can be used in medicine, urology. EFFECT: enhanced antidiuretic activity of the end product.
Claims (1)
Тиосалицилоилгидразон 4-фторбензальдегида формулы
проявляющий антидиуретическую активность.Thiosalicyloylhydrazone 4-fluorobenzaldehyde of the formula